DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Soelberg Sorensen P, Drulovic J, Havrdova E et al.
Magnetic resonance imaging (MRI) efficacy of ofatumumab in relapsing-remitting multiple sclerosis (RRMS) – 24-week results of a phase II study.
Multiple Sclerosis 2010;
16: S37
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.